Dutch Heart Foundation, UMC Groningen and Pivot Park Screening Centre collaborate on heart failure High number of SMEs benefit greatly from the European Lead Factory
Scientists from UMC Groningen and Pivot Park Screening Centre have started a study with the objective to prevent one of...
Read more
Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer
Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer under Janssen Strategic Partnership for ADU-214 in Combination with Nivolumab
Read more
Binding term sheet for allogeneic CAR-NK therapies
MolMed and Glycostem announce the execution of a binding term sheet for the development and manufacturing of allogeneic CAR-NK therapies.
Read more
Prexton Therapeutics acquired by Lundbeck
H. Lundbeck A/S (Lundbeck) and Prexton Therapeutics BV (Prexton) announced March 16th the signing of a definitive agreement in which Lundbeck will acquire Prexton.
Read more
Ardena acquires ChemConnection adding API expertise
Contract development and manufacturing organisation (CDMO) Ardena has acquired ChemConnection.
Read more
InnatOss and MediSapiens Receive EU Grant to Personalize Lyme Diagnostics
Recently the number of companies based at Pivot Park reached the milestone of 50!
Read more
ImmunoPrecise to Acquire ModiQuest Research BV
IMMUNOPRECISE ANTIBODIES LTD. announces that it has signed a binding letter of intent with ModiQuest Research BV.
Read more
Anglo-Dutch research teams awarded Eurostars funding for a €1.1M project to develop a synthetic matrix for 3D organoid cell culture
Researchers at Maastricht University, Noviocell BV (based at Pivot Park) and Cell Guidance Systems Ltd are collaborating on an EU funded Eurostars project to develop fully-defined matrices for the 3D culture of organoids.
Read more
Ceres InnatOss to Launch the Nanotrap® Lyme Antigen Test in the EU
Ceres and Innatoss announced today a partnership that will deliver the Nanotrap® Lyme Antigen Test in the EU.
Read more